“Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India” (2023) Monaldi Archives for Chest Disease, 93(4). doi:10.4081/monaldi.2023.2449.